Other Assets, Current in USD of AVADEL PHARMACEUTICALS PLC from Q4 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
AVADEL PHARMACEUTICALS PLC quarterly Other Assets, Current history and change rate from Q4 2012 to Q3 2025.
  • AVADEL PHARMACEUTICALS PLC Other Assets, Current for the quarter ending 30 Sep 2025 was $798K, a 59% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Change (%)

AVADEL PHARMACEUTICALS PLC Quarterly Other Assets, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $798K -$1.15M -59% 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 $773K +$101K +15% 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $825K -$2.5M -75.2% 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $882K -$1.35M -60.5% 31 Dec 2024 10-Q 04 Nov 2025
Q3 2024 $1.95M +$1.17M +150% 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $672K -$75K -10% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $3.32M +$2.78M +513% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $2.24M +$1.66M +290% 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 $779K +$212K +37.4% 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $747K +$544K +268% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $542K +$386K +247% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $573K +$302K +111% 31 Dec 2022 10-K 29 Feb 2024
Q3 2022 $567K +$185K +48.4% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $203K -$289K -58.7% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $156K +$7K +4.7% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $271K -$527K -66% 31 Dec 2021 10-K 29 Mar 2023
Q3 2021 $382K +$291K +320% 30 Sep 2021 10-Q 08 Nov 2021
Q2 2021 $492K +$198K +67.3% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $149K -$6K -3.87% 31 Mar 2021 10-Q 10 May 2021
Q4 2020 $798K +$691K +646% 31 Dec 2020 10-K 16 Mar 2022
Q3 2020 $91K -$84K -48% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $294K +$212K +259% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $155K -$885K -85.1% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 $107K -$118K -52.4% 31 Dec 2019 10-K 09 Mar 2021
Q3 2019 $175K 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 $82K 30 Jun 2019 10-Q 09 Aug 2019
Q1 2019 $1.04M 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $225K +$97K +75.8% 31 Dec 2018 10-K 16 Mar 2020
Q4 2017 $128K 31 Dec 2017 10-K 15 Mar 2019
Q4 2014 $5K -$90K -94.7% 31 Dec 2014 20-F 01 Oct 2015
Q4 2013 $95K +$95K 31 Dec 2013 20-F 01 Oct 2015
Q4 2012 $0 31 Dec 2012 20-F/A 30 Apr 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.